Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.19 trillion and total revenue of $110.17 billion.
Market Cap
1.19T
Revenue
110.17B
Profits
-39.88B
PE Ratio
n/a
Profit Margin
-36.20%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.33B | 0.25% | 734,334 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.61B | -0.10% | 901,856 | 14.34B |
| 3 | ARGX | argenx SE | 49.44B | -1.51% | 380,820 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.19B | 0.70% | 1,003,652 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.65B | 0.03% | 183,124 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.19B | 2.48% | 1,819,999 | 606.42M |
| 7 | RVMD | Revolution Medicines, Inc. | 29.76B | -4.97% | 3,731,761 | - |
| 8 | RPRX | Royalty Pharma plc | 29.47B | 0.49% | 2,617,984 | 2.38B |
| 9 | BNTX | BioNTech SE | 27.46B | -2.69% | 1,214,165 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 22.05B | 2.53% | 3,506,516 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.86B | -0.48% | 8,451,801 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.25B | 0.54% | 1,012,603 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 19.06B | -6.82% | 8,248,900 | - |
| 14 | GMAB | Genmab A/S | 17.10B | 2.33% | 1,861,406 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.43B | -2.28% | 1,484,486 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.27B | -3.85% | 1,809,578 | 845.52M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.46B | 1.69% | 1,053,284 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | 0.07% | 2,024,003 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.14B | 0.27% | 199,173 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.90B | 2.09% | 3,533,576 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -0.86% | 1,283,471 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.35B | 4.04% | 2,190,060 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.54B | 1.89% | 614,458 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.39B | -1.04% | 203,656 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.20B | 4.09% | 656,797 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 9.17B | -1.83% | 1,132,715 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.75B | 0.43% | 817,213 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.56B | 1.61% | 581,475 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.33B | -0.37% | 11,414,438 | 113.29M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.16B | 0.68% | 1,181,379 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 8.12B | 1.20% | 367,722 | 389.13M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -0.01% | 853,808 | 1.40B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.25B | 0.79% | 420,055 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | 0.02% | 1,044,553 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.74B | -0.32% | 345,923 | 46.02M |
| 36 | ERAS | Erasca, Inc. | 6.73B | -3.39% | 11,240,267 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.70B | -0.20% | 536,121 | - |
| 38 | BLTE | Belite Bio, Inc | 6.59B | 1.33% | 88,162 | - |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.30B | 2.43% | 1,070,643 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.05% | 3,483,245 | 15.00M |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.04% | 2,702,102 | - |
| 42 | IMVT | Immunovant, Inc. | 6.00B | 4.28% | 1,855,191 | - |
| 43 | CELC | Celcuity Inc. | 5.92B | -2.90% | 506,161 | - |
| 44 | CGON | CG Oncology, Inc. | 5.90B | -2.73% | 1,040,108 | 4.04M |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.86B | 0.31% | 514,206 | 1.73B |
| 46 | COGT | Cogent Biosciences, Inc. | 5.86B | -0.93% | 1,424,254 | - |
| 47 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.82B | 0.30% | 974,036 | 189.76M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.79B | -1.58% | 1,301,913 | 812.03M |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.69B | 1.05% | 729,524 | 521.31M |
| 50 | TGTX | TG Therapeutics, Inc. | 5.66B | 5.60% | 2,297,669 | 616.29M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.44B | -1.60% | 970,895 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.43B | 1.58% | 1,426,839 | 3.51M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | 0.44% | 720,818 | 7.50M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | -0.12% | 2,180,583 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.97B | 1.26% | 303,446 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.95B | 3.26% | 727,097 | 761.41M |
| 57 | LEGN | Legend Biotech Corporation | 4.80B | 2.82% | 3,256,835 | 1.03B |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 2,703,456 | 634.21M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 4.52B | 0.09% | 113,896 | 268.09M |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | 0.51% | 785,292 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.97B | 1.33% | 1,609,949 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.89B | -2.99% | 3,157,131 | 62.38M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.79B | 2.02% | 1,180,129 | 1.07B |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.70B | 3.38% | 2,679,940 | 490.73M |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | -1.66% | 1,652,672 | 22.50M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.48B | 0.98% | 151,837 | 803.79M |
| 67 | ORKA | Oruka Therapeutics, Inc. | 3.45B | 0.99% | 1,141,885 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.45B | -0.86% | 658,036 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.34B | 8.56% | 4,112,689 | 247.00M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.29B | -0.70% | 688,825 | - |
| 71 | ALMS | Alumis Inc. | 3.29B | 3.64% | 1,406,378 | 24.05M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.25B | 2.39% | 2,148,963 | - |
| 73 | DNLI | Denali Therapeutics Inc. | 3.21B | 0.60% | 1,424,877 | - |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.17B | 1.17% | 703,252 | 588.99M |
| 75 | BEAM | Beam Therapeutics Inc. | 3.15B | 3.26% | 1,665,001 | 139.74M |
| 76 | RLAY | Relay Therapeutics, Inc. | 3.12B | -1.73% | 2,367,705 | 15.36M |
| 77 | KLRA | Kailera Therapeutics, Inc. | 3.01B | -3.65% | 891,939 | - |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.95B | 1.50% | 826,091 | 376.07M |
| 79 | VERA | Vera Therapeutics, Inc. | 2.89B | 0.52% | 651,271 | - |
| 80 | KOD | Kodiak Sciences Inc. | 2.79B | -2.06% | 434,595 | - |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 2.78B | -0.50% | 983,821 | 218.71M |
| 82 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.11% | 1,653,471 | 190.41M |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | -1.60% | 542,911 | 451.36M |
| 84 | IMNM | Immunome, Inc. | 2.69B | -0.29% | 669,687 | 6.94M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.68B | -0.12% | 787,270 | 1.55M |
| 86 | NKTR | Nektar Therapeutics | 2.67B | -5.05% | 3,715,750 | 55.23M |
| 87 | IRON | Disc Medicine, Inc. | 2.66B | 0.91% | 386,319 | - |
| 88 | ELVN | Enliven Therapeutics, Inc. | 2.66B | -3.16% | 744,159 | - |
| 89 | MANE | Veradermics, Incorporated | 2.63B | -4.14% | 433,844 | - |
| 90 | ZLAB | Zai Lab Limited | 2.57B | -6.42% | 820,825 | 460.16M |
| 91 | ADMA | ADMA Biologics, Inc. | 2.54B | 1.58% | 5,094,811 | 510.17M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | 2.12% | 1,349,181 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.52% | 598,213 | - |
| 94 | AAPG | Ascentage Pharma Group International | 2.34B | -2.03% | 1,494 | 82.08M |
| 95 | DFTX | Definium Therapeutics, Inc. | 2.30B | -3.19% | 1,812,993 | - |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.19% | 2,988,826 | 158.18M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.22B | 1.80% | 948,163 | - |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | -0.07% | 1,040,237 | 276.98M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 3.79% | 1,216,937 | 283.06M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -0.19% | 2,564,925 | 2.20B |
| 101 | STOK | Stoke Therapeutics, Inc. | 2.12B | 0.81% | 448,962 | 184.42M |
| 102 | ZYME | Zymeworks Inc. | 2.10B | 0.92% | 715,613 | 105.97M |
| 103 | OCUL | Ocular Therapeutix, Inc. | 2.10B | 3.65% | 2,810,782 | 51.95M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.07B | 1.23% | 1,339,944 | - |
| 105 | MESO | Mesoblast Limited | 2.05B | -2.72% | 230,195 | 65.38M |
| 106 | CAPR | Capricor Therapeutics, Inc. | 2.02B | -0.96% | 591,233 | 11.13M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.97B | 4.78% | 10,281,978 | 74.68M |
| 108 | PHVS | Pharvaris N.V. | 1.96B | 3.05% | 239,282 | - |
| 109 | NTLA | Intellia Therapeutics, Inc. | 1.96B | 8.23% | 3,762,626 | 67.67M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | -5.36% | 2,258,355 | 172.35M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.94B | 3.37% | 363,351 | - |
| 112 | TSHA | Taysha Gene Therapies, Inc. | 1.93B | 8.04% | 3,073,321 | 9.77M |
| 113 | GLPG | Galapagos NV | 1.92B | 0.76% | 82,792 | 1.31B |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.87B | -0.01% | 196,722 | - |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.85B | -0.53% | 1,484,242 | 868.45M |
| 116 | NUVB | Nuvation Bio Inc. | 1.78B | 0.20% | 2,517,135 | 62.90M |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.76B | -0.46% | 338,397 | - |
| 118 | VCEL | Vericel Corporation | 1.75B | 2.08% | 457,612 | 276.26M |
| 119 | INVA | Innoviva, Inc. | 1.74B | -0.47% | 448,663 | 411.33M |
| 120 | VIR | Vir Biotechnology, Inc. | 1.72B | -1.48% | 2,405,465 | 68.56M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 1.16% | 694,656 | 71.78M |
| 122 | ATAI | AtaiBeckley Inc. | 1.72B | -3.29% | 6,635,984 | 4.09M |
| 123 | INBX | Inhibrx Biosciences, Inc. | 1.68B | 36.88% | 2,735,062 | 1.30M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.68B | 0.43% | 1,103,123 | 123.67M |
| 125 | GENB | Generate Biomedicines, Inc. | 1.66B | 2.84% | 329,484 | 31.89M |
| 126 | OCS | Oculis Holding AG | 1.65B | 1.64% | 909,365 | 1.51M |
| 127 | BHVN | Biohaven Ltd. | 1.61B | 4.81% | 1,579,342 | - |
| 128 | MBX | MBX Biosciences, Inc. | 1.60B | 1.02% | 341,752 | - |
| 129 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | 1.64% | 1,586,317 | 54.03M |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.56B | -3.43% | 153,667 | - |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.55B | 2.25% | 603,440 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.54B | 3.34% | 605,317 | 234.60M |
| 133 | NBTX | Nanobiotix S.A. | 1.54B | 4.53% | 41,310 | 38.27M |
| 134 | IMCR | Immunocore Holdings plc | 1.52B | 1.56% | 341,191 | 400.02M |
| 135 | IMTX | Immatics N.V. | 1.51B | 0.72% | 180,599 | 56.67M |
| 136 | CRVS | Corvus Pharmaceuticals, Inc. | 1.50B | 4.14% | 3,376,360 | - |
| 137 | VRDN | Viridian Therapeutics, Inc. | 1.48B | 0.35% | 1,400,249 | 70.85M |
| 138 | ARDX | Ardelyx, Inc. | 1.48B | 1.01% | 2,963,214 | 407.32M |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.59% | 22,203,968 | 263.50M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.42B | 0.54% | 3,550,837 | 42.73M |
| 141 | OLMA | Olema Pharmaceuticals, Inc. | 1.42B | -2.35% | 953,455 | - |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.41B | 16.33% | 610,023 | - |
| 143 | PGEN | Precigen, Inc. | 1.40B | -0.50% | 1,640,417 | 9.68M |
| 144 | NVAX | Novavax, Inc. | 1.38B | -0.47% | 3,523,198 | 1.12B |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -0.27% | 247,039 | - |
| 146 | MAZE | Maze Therapeutics, Inc. | 1.32B | 3.15% | 2,220,576 | 2.50M |
| 147 | SVRA | Savara Inc. | 1.30B | -2.65% | 1,393,241 | - |
| 148 | URGN | UroGen Pharma Ltd. | 1.27B | 4.12% | 1,779,080 | 109.79M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.25B | 10.30% | 1,261,503 | - |
| 150 | ABCL | AbCellera Biologics Inc. | 1.24B | 2.26% | 5,347,643 | 75.13M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.24B | - | 1,213,288 | - |
| 152 | AKTS | Aktis Oncology, Inc. | 1.22B | 7.32% | 302,813 | 6.50M |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.19B | -1.81% | 507,482 | 10.00M |
| 154 | PHAR | Pharming Group N.V. | 1.19B | -0.29% | 3,544 | 376.13M |
| 155 | EYPT | EyePoint, Inc. | 1.19B | 0.92% | 989,008 | 31.37M |
| 156 | GHRS | GH Research PLC | 1.18B | -8.23% | 533,594 | - |
| 157 | DBVT | DBV Technologies S.A. | 1.16B | -1.05% | 292,236 | 5.64M |
| 158 | SEPN | Septerna, Inc. | 1.16B | 0.23% | 255,587 | 45.95M |
| 159 | QURE | uniQure N.V. | 1.12B | 1.89% | 594,026 | 16.10M |
| 160 | IVA | Inventiva S.A. | 1.11B | -2.78% | 142,731 | 7.94M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 1.32% | 1,741,665 | - |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 2.55% | 1,428,126 | 291.85M |
| 163 | ANNX | Annexon, Inc. | 1.02B | 0.97% | 1,848,122 | - |
| 164 | SANA | Sana Biotechnology, Inc. | 1.01B | -0.27% | 2,321,663 | - |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 0.67% | 988,938 | 73.62M |
| 166 | CTMX | CytomX Therapeutics, Inc. | 996.58M | -3.15% | 3,003,935 | 76.20M |
| 167 | GERN | Geron Corporation | 993.40M | 3.33% | 16,683,710 | 183.88M |
| 168 | FTRE | Fortrea Holdings Inc. | 981.75M | 1.74% | 900,248 | 2.72B |
| 169 | EVMN | Evommune, Inc. | 976.82M | -3.38% | 126,633 | 13.00M |
| 170 | OMER | Omeros Corporation | 962.59M | 0.83% | 890,414 | - |
| 171 | CMPX | Compass Therapeutics, Inc. | 958.07M | 1.53% | 1,848,926 | 850.00K |
| 172 | ANRO | Alto Neuroscience, Inc. | 952.03M | 6.14% | 335,643 | - |
| 173 | MRVI | Maravai LifeSciences Holdings, Inc. | 948.58M | 0.27% | 2,462,404 | 185.74M |
| 174 | XNCR | Xencor, Inc. | 942.40M | 1.90% | 630,860 | 125.58M |
| 175 | JANX | Janux Therapeutics, Inc. | 936.20M | -0.45% | 612,978 | 10.00M |
| 176 | PHAT | Phathom Pharmaceuticals, Inc. | 931.72M | -8.93% | 2,043,455 | 175.11M |
| 177 | MGTX | MeiraGTx Holdings plc | 928.35M | -1.38% | 1,002,599 | 81.39M |
| 178 | LBRX | LB Pharmaceuticals Inc | 911.29M | - | 254,010 | - |
| 179 | CBIO | Crescent Biopharma, Inc. | 896.11M | 9.81% | 583,248 | 10.84M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 875.40M | 3.12% | 153,487 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 872.44M | - | 938,948 | 14.08M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 858.40M | -4.97% | 5,293,511 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 853.24M | -0.30% | 445,035 | 107.46M |
| 184 | MNKD | MannKind Corporation | 846.10M | 1.48% | 3,928,163 | 348.97M |
| 185 | KURA | Kura Oncology, Inc. | 845.91M | 0.63% | 982,763 | 67.48M |
| 186 | CGEM | Cullinan Therapeutics, Inc. | 837.68M | -2.67% | 481,373 | - |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 834.10M | 7.14% | 3,892,067 | 84.28M |
| 188 | VOR | Vor Biopharma Inc. | 830.12M | 0.99% | 1,047,651 | - |
| 189 | SLDB | Solid Biosciences Inc. | 826.52M | 2.94% | 733,065 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 824.56M | 0.60% | 493,739 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 822.11M | 3.02% | 9,426,378 | 22.00K |
| 192 | SGP | SpyGlass Pharma, Inc. | 818.62M | 0.84% | 54,813 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 771.10M | -0.55% | 1,401,918 | 49.80M |
| 194 | RLMD | Relmada Therapeutics, Inc. | 740.51M | -1.12% | 1,203,821 | - |
| 195 | FBRX | Forte Biosciences, Inc. | 730.19M | -9.17% | 227,100 | - |
| 196 | DRTS | Alpha Tau Medical Ltd. | 711.12M | 2.28% | 142,352 | - |
| 197 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 709.89M | -6.24% | 796,529 | - |
| 198 | GYRE | Gyre Therapeutics, Inc. | 705.86M | -1.78% | 34,303 | 116.59M |
| 199 | PRME | Prime Medicine, Inc. | 701.24M | 3.94% | 1,772,368 | 4.63M |
| 200 | TENX | Tenax Therapeutics, Inc. | 700.18M | 1.75% | 456,530 | - |
| 201 | ARVN | Arvinas, Inc. | 679.91M | 0.09% | 648,439 | 262.60M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 655.71M | 11.00% | 843,404 | - |
| 203 | ANL | Adlai Nortye Ltd. | 645.20M | 1.07% | 550,597 | 5.00M |
| 204 | PROK | ProKidney Corp. | 631.00M | - | 571,293 | 893.00K |
| 205 | EIKN | Eikon Therapeutics, Inc. | 628.01M | -1.19% | 132,800 | - |
| 206 | KYTX | Kyverna Therapeutics, Inc. | 619.22M | 5.36% | 6,106,870 | - |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 615.88M | 0.96% | 803,408 | 106.47M |
| 208 | ACRS | Aclaris Therapeutics, Inc. | 610.19M | 5.28% | 2,272,504 | 7.83M |
| 209 | STRO | Sutro Biopharma, Inc. | 588.63M | 3.44% | 217,584 | 102.48M |
| 210 | CRMD | CorMedix Inc. | 587.43M | 1.49% | 882,385 | 311.71M |
| 211 | STTK | Shattuck Labs, Inc. | 585.76M | -0.13% | 410,203 | 1.00M |
| 212 | LYEL | Lyell Immunopharma, Inc. | 578.08M | 3.64% | 71,996 | 36.00K |
| 213 | PRTA | Prothena Corporation plc | 577.09M | 0.47% | 350,784 | 9.68M |
| 214 | ENGN | enGene Therapeutics Inc. | 572.09M | 0.35% | 340,973 | - |
| 215 | OCGN | Ocugen, Inc. | 567.67M | -5.08% | 12,455,440 | 4.41M |
| 216 | ABSI | Absci Corporation | 563.12M | -5.64% | 5,640,867 | 2.80M |
| 217 | RIGL | Rigel Pharmaceuticals, Inc. | 562.88M | -5.64% | 522,348 | 294.28M |
| 218 | ZURA | Zura Bio Limited | 539.87M | 7.56% | 737,263 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 539.66M | 5.17% | 596,581 | - |
| 220 | CADL | Candel Therapeutics, Inc. | 537.63M | 4.86% | 2,548,739 | - |
| 221 | TECX | Tectonic Therapeutic, Inc. | 535.13M | 3.11% | 242,707 | - |
| 222 | VSTM | Verastem, Inc. | 533.21M | 0.33% | 1,600,514 | 30.91M |
| 223 | UPB | Upstream Bio, Inc. | 524.61M | 4.10% | 624,770 | 2.85M |
| 224 | ADCT | ADC Therapeutics SA | 520.21M | -0.49% | 651,454 | 81.36M |
| 225 | FULC | Fulcrum Therapeutics, Inc. | 516.15M | 2.92% | 816,781 | 80.00M |
| 226 | AGMB | AgomAb Therapeutics NV | 514.17M | -3.65% | 64,761 | - |
| 227 | ARMP | Armata Pharmaceuticals, Inc. | 509.56M | -6.01% | 63,425 | 4.90M |
| 228 | VTVT | vTv Therapeutics Inc. | 501.97M | 5.06% | 126,139 | 17.00K |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 500.30M | 0.41% | 685,415 | 85.21M |
| 230 | MDXG | MiMedx Group, Inc. | 491.76M | 3.44% | 1,428,517 | 418.63M |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 491.27M | 2.80% | 846,244 | 170.16M |
| 232 | VALN | Valneva SE | 485.03M | -11.47% | 463,795 | 205.07M |
| 233 | CTNM | Contineum Therapeutics, Inc. | 483.88M | -1.44% | 237,139 | - |
| 234 | RGNX | REGENXBIO Inc. | 482.10M | 2.52% | 401,470 | 170.44M |
| 235 | AURA | Aura Biosciences, Inc. | 480.49M | 0.67% | 261,739 | - |
| 236 | LRMR | Larimar Therapeutics, Inc. | 473.71M | -0.22% | 1,000,628 | - |
| 237 | TRDA | Entrada Therapeutics, Inc. | 469.80M | -0.15% | 169,400 | 25.42M |
| 238 | XOMA | XOMA Royalty Corporation | 469.12M | -0.53% | 150,528 | 52.15M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 468.97M | 0.64% | 1,062,672 | - |
| 240 | IVVD | Invivyd, Inc. | 452.49M | 0.63% | 1,249,017 | 53.43M |
| 241 | ALT | Altimmune, Inc. | 451.46M | 1.76% | 2,948,086 | 41.00K |
| 242 | ASMB | Assembly Biosciences, Inc. | 448.91M | 5.01% | 80,933 | 72.30M |
| 243 | AVIR | Atea Pharmaceuticals, Inc. | 446.96M | 1.63% | 170,312 | - |
| 244 | CLYM | Climb Bio, Inc. | 444.25M | -0.75% | 1,532,335 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 443.94M | -1.67% | 107,293 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 440.24M | 6.30% | 1,016,384 | 109.16M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.80M | 0.57% | 126,657 | - |
| 248 | PRLD | Prelude Therapeutics Incorporated | 433.38M | -6.71% | 321,031 | 12.14M |
| 249 | NGNE | Neurogene Inc. | 425.84M | 2.91% | 109,204 | 925.00K |
| 250 | AUTL | Autolus Therapeutics plc | 425.83M | 3.23% | 1,037,323 | 75.39M |
| 251 | PRTC | PureTech Health plc | 424.18M | -1.11% | 4,095 | 6.39M |
| 252 | NMRA | Neumora Therapeutics, Inc. | 420.51M | -0.43% | 1,566,694 | - |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 414.67M | 3.83% | 1,559,649 | - |
| 254 | LCTX | Lineage Cell Therapeutics, Inc. | 406.01M | -0.61% | 434,011 | 14.56M |
| 255 | VNDA | Vanda Pharmaceuticals Inc. | 403.71M | 0.74% | 948,975 | 216.11M |
| 256 | NAGE | Niagen Bioscience, Inc. | 402.84M | 5.91% | 930,041 | 129.42M |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 401.87M | 6.00% | 681,045 | 35.11M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 400.18M | 4.15% | 113,740 | 66.98M |
| 259 | PALI | Palisade Bio, Inc. | 391.77M | -16.43% | 9,014,094 | - |
| 260 | IRD | Opus Genetics, Inc. | 389.19M | 2.43% | 570,554 | 14.20M |
| 261 | AVTX | Avalo Therapeutics, Inc. | 387.36M | 1.47% | 611,854 | 59.00K |
| 262 | IMRX | Immuneering Corporation | 380.81M | 6.13% | 902,506 | - |
| 263 | SRZN | Surrozen, Inc. | 379.41M | 6.21% | 218,798 | 3.48M |
| 264 | PBYI | Puma Biotechnology, Inc. | 378.01M | 2.34% | 198,806 | 228.37M |
| 265 | SLN | Silence Therapeutics plc | 376.45M | 3.10% | 450,213 | 559.00K |
| 266 | YDES | YD Bio Limited | 374.10M | 3.10% | 23,634 | 510.36K |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 363.24M | 3.24% | 359,496 | - |
| 268 | MNPR | Monopar Therapeutics Inc. | 356.69M | 1.12% | 152,611 | - |
| 269 | CABA | Cabaletta Bio, Inc. | 352.89M | 1.28% | 1,387,438 | - |
| 270 | OVID | Ovid Therapeutics Inc. | 350.79M | -6.67% | 2,022,835 | 7.25M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 348.62M | 0.78% | 142,010 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 347.84M | 1.22% | 373,601 | 72.59M |
| 273 | RZLT | Rezolute, Inc. | 345.89M | 1.52% | 1,664,564 | - |
| 274 | GLSI | Greenwich LifeSciences, Inc. | 345.53M | 8.86% | 129,248 | - |
| 275 | AVXL | Anavex Life Sciences Corp. | 334.55M | 3.14% | 752,230 | - |
| 276 | EDIT | Editas Medicine, Inc. | 325.91M | 0.91% | 1,093,385 | 40.52M |
| 277 | NGEN | NervGen Pharma Corp. | 325.75M | 3.74% | 161,748 | - |
| 278 | NERV | Minerva Neurosciences, Inc. | 322.24M | 5.45% | 142,833 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 321.19M | 4.65% | 1,046,950 | 5.82M |
| 280 | FHTX | Foghorn Therapeutics Inc. | 316.39M | 2.28% | 106,159 | 30.91M |
| 281 | LENZ | LENZ Therapeutics, Inc. | 313.23M | 1.22% | 947,312 | 19.09M |
| 282 | IKT | Inhibikase Therapeutics, Inc. | 310.17M | 8.98% | 956,999 | 1.00 |
| 283 | ACIU | AC Immune SA | 303.56M | 6.62% | 149,842 | 4.51M |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 303.11M | 0.76% | 1,660,855 | - |
| 285 | CCCC | C4 Therapeutics, Inc. | 299.56M | -1.60% | 1,597,813 | 35.95M |
| 286 | NBP | NovaBridge Biosciences | 298.37M | 0.39% | 379,914 | - |
| 287 | TARA | Protara Therapeutics, Inc. | 292.60M | 1.69% | 440,276 | - |
| 288 | ARTV | Artiva Biotherapeutics, Inc. | 289.93M | -6.46% | 393,369 | 251.00K |
| 289 | HELP | Cybin Inc. | 288.71M | 17.04% | 2,533,214 | - |
| 290 | CLLS | Cellectis S.A. | 283.29M | -0.50% | 25,980 | 79.59M |
| 291 | SABS | SAB Biotherapeutics, Inc. | 280.40M | 4.72% | 442,195 | 114.70K |
| 292 | CHRS | Coherus Oncology, Inc. | 277.59M | -1.10% | 816,765 | 42.17M |
| 293 | ZNTL | Zentalis Pharmaceuticals, Inc. | 272.38M | -3.76% | 1,434,429 | 26.87M |
| 294 | ALEC | Alector, Inc. | 270.39M | -0.41% | 1,421,359 | 21.05M |
| 295 | CGEN | Compugen Ltd. | 267.59M | -0.35% | 302,932 | 72.76M |
| 296 | PLYX | Polaryx Therapeutics, Inc. | 260.86M | 4.55% | 119,895 | - |
| 297 | ADAG | Adagene Inc. | 249.75M | -0.53% | 118,048 | 7.67M |
| 298 | VYGR | Voyager Therapeutics, Inc. | 246.74M | 0.49% | 429,573 | 40.37M |
| 299 | MIST | Milestone Pharmaceuticals Inc. | 246.53M | 4.69% | 1,676,970 | 1.55M |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 246.37M | -0.47% | 192,140 | 33.48M |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.01M | -2.27% | 325,563 | 82.03M |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 238.88M | -3.71% | 28,556 | 19.39M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 236.23M | -1.52% | 68,256 | 3.50M |
| 304 | NVCT | Nuvectis Pharma, Inc. | 233.66M | 2.80% | 50,398 | - |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 230.81M | 2.37% | 110,507 | 44.64M |
| 306 | CRBU | Caribou Biosciences, Inc. | 228.06M | 4.89% | 1,443,091 | 11.16M |
| 307 | KROS | Keros Therapeutics, Inc. | 225.57M | 1.15% | 184,182 | 244.06M |
| 308 | ACHV | Achieve Life Sciences, Inc. | 225.21M | 0.48% | 806,323 | - |
| 309 | CDXS | Codexis, Inc. | 224.45M | 2.49% | 815,017 | 70.39M |
| 310 | ALXO | ALX Oncology Holdings Inc. | 223.73M | - | 2,425,652 | - |
| 311 | CNTX | Context Therapeutics Inc. | 221.43M | 1.69% | 623,749 | - |
| 312 | ELTX | Elicio Therapeutics, Inc. | 220.38M | -1.64% | 51,284 | - |
| 313 | NKTX | Nkarta, Inc. | 220.29M | -6.93% | 1,397,559 | - |
| 314 | MDWD | MediWound Ltd. | 219.52M | 2.89% | 49,686 | 16.96M |
| 315 | MGNX | MacroGenics, Inc. | 217.38M | -1.44% | 453,372 | 149.50M |
| 316 | OABI | OmniAb, Inc. | 217.17M | 1.35% | 1,523,360 | 18.67M |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 215.29M | 4.14% | 486,145 | 146.07M |
| 318 | ENLV | Enlivex Ltd. | 210.94M | 1.15% | 389,900 | - |
| 319 | SGMT | Sagimet Biosciences Inc. | 204.63M | 6.26% | 271,179 | - |
| 320 | DTIL | Precision BioSciences, Inc. | 204.10M | 6.32% | 162,951 | 34.26M |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 202.92M | 2.93% | 311,772 | - |
| 322 | KRRO | Korro Bio, Inc. | 201.77M | 3.71% | 60,593 | 6.39M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 201.13M | 6.93% | 632,107 | - |
| 324 | WHWK | Whitehawk Therapeutics, Inc. | 200.11M | 0.95% | 126,396 | 7.15M |
| 325 | UNCY | Unicycive Therapeutics, Inc. | 194.58M | 6.93% | 758,360 | - |
| 326 | HRTX | Heron Therapeutics, Inc. | 192.31M | - | 1,385,175 | 154.90M |
| 327 | BDTX | Black Diamond Therapeutics, Inc. | 191.92M | 6.35% | 1,190,011 | 70.00M |
| 328 | REPL | Replimune Group, Inc. | 187.44M | 22.04% | 17,954,687 | - |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 186.23M | -2.96% | 398,291 | 13.11M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 185.88M | 1.75% | 324,482 | - |
| 331 | PRQR | ProQR Therapeutics N.V. | 184.38M | 0.86% | 1,485,737 | 19.19M |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 182.65M | -0.29% | 104,715 | 2.80M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 177.26M | -0.90% | 499,020 | 52.74M |
| 334 | MENS | Jyong Biotech Ltd. | 174.56M | 6.57% | 61,323 | - |
| 335 | HURA | TuHURA Biosciences, Inc. | 170.39M | -3.60% | 1,484,179 | - |
| 336 | SPRO | Spero Therapeutics, Inc. | 165.57M | 2.14% | 319,043 | 66.80M |
| 337 | KALA | KALA BIO, Inc. | 164.06M | -4.65% | 3,979,098 | - |
| 338 | MOLN | Molecular Partners AG | 163.95M | -0.23% | 1,310 | 856.30K |
| 339 | GALT | Galectin Therapeutics Inc. | 161.28M | 7.46% | 290,411 | - |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 159.73M | 6.22% | 2,934,976 | - |
| 341 | FATE | Fate Therapeutics, Inc. | 159.28M | 1.48% | 702,521 | 6.65M |
| 342 | TLSA | Tiziana Life Sciences Ltd | 158.25M | 0.81% | 95,136 | - |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 157.74M | 1.30% | 98,097 | 2.00M |
| 344 | HUMA | Humacyte, Inc. | 156.50M | 6.97% | 4,651,908 | 2.04M |
| 345 | ACOG | Alpha Cognition Inc. | 152.20M | 1.60% | 41,197 | 10.22M |
| 346 | AGEN | Agenus Inc. | 151.29M | 0.77% | 770,656 | 114.20M |
| 347 | EQ | Equillium, Inc. | 147.32M | 8.37% | 742,548 | 4.39M |
| 348 | CNTB | Connect Biopharma Holdings Limited | 146.96M | 0.78% | 216,770 | 64.00K |
| 349 | KLRS | Kalaris Therapeutics, Inc. | 145.14M | 0.80% | 53,718 | - |
| 350 | ANTX | AN2 Therapeutics, Inc. | 143.94M | 5.26% | 218,836 | - |
| 351 | BMEA | Biomea Fusion, Inc. | 133.75M | -3.14% | 1,624,025 | - |
| 352 | ONCY | Oncolytics Biotech Inc. | 133.55M | 2.68% | 732,895 | - |
| 353 | SPRB | Spruce Biosciences, Inc. | 132.07M | 1.30% | 186,286 | 697.00K |
| 354 | KZIA | Kazia Therapeutics Limited | 131.75M | 12.60% | 1,079,001 | 1.27M |
| 355 | IPHA | Innate Pharma S.A. | 129.31M | -5.30% | 25,444 | 10.57M |
| 356 | NTHI | NeOnc Technologies Holdings, Inc. | 123.31M | -3.51% | 26,569 | 39.99K |
| 357 | AARD | Aardvark Therapeutics, Inc. | 120.64M | 2.98% | 149,867 | - |
| 358 | CRDF | Cardiff Oncology, Inc. | 118.27M | 4.85% | 573,382 | 593.00K |
| 359 | PYXS | Pyxis Oncology, Inc. | 118.12M | 9.94% | 680,361 | 13.86M |
| 360 | IMUX | Immunic, Inc. | 117.42M | -0.10% | 2,617,039 | - |
| 361 | IFRX | InflaRx N.V. | 115.67M | -7.51% | 968,837 | 34.44K |
| 362 | CGTX | Cognition Therapeutics, Inc. | 115.27M | 10.26% | 1,532,681 | - |
| 363 | PEPG | PepGen Inc. | 114.73M | 3.11% | 766,767 | - |
| 364 | CBUS | Cibus, Inc. | 113.50M | - | 291,758 | 3.64M |
| 365 | GNLX | Genelux Corporation | 112.71M | -0.78% | 118,798 | 8.00K |
| 366 | VANI | Vivani Medical, Inc. | 112.58M | -3.62% | 387,290 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 111.75M | 2.93% | 19,777 | 35.58M |
| 368 | SEER | Seer, Inc. | 111.43M | -1.25% | 268,552 | 16.58M |
| 369 | SGMO | Sangamo Therapeutics, Inc. | 106.84M | 0.16% | 3,780,130 | 39.55M |
| 370 | ANIX | Anixa Biosciences, Inc. | 105.28M | 9.03% | 243,014 | - |
| 371 | COYA | Coya Therapeutics, Inc. | 103.45M | -2.54% | 160,610 | 7.95M |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 102.31M | 1.19% | 1,078,913 | - |
| 373 | TTRX | Turn Therapeutics Inc. | 101.58M | 1.79% | 6,766 | - |
| 374 | PMN | ProMIS Neurosciences, Inc. | 99.63M | 3.54% | 31,900 | - |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 98.11M | 0.68% | 1,199,722 | 1.23M |
| 376 | QTTB | Q32 Bio Inc. | 97.29M | 3.58% | 406,312 | 53.74M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 94.82M | 0.23% | 703,928 | 1.63M |
| 378 | COEP | Coeptis Therapeutics Holdings, Inc. | 93.97M | 1.14% | 42,896 | 1.36M |
| 379 | GUTS | Fractyl Health, Inc. | 93.68M | 2.70% | 1,019,924 | 3.00K |
| 380 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | 0.88% | 698,668 | 65.34K |
| 381 | GOSS | Gossamer Bio, Inc. | 91.51M | 3.31% | 4,799,087 | 48.47M |
| 382 | PYPD | PolyPid Ltd. | 89.88M | 3.74% | 39,846 | - |
| 383 | ACET | Adicet Bio, Inc. | 89.33M | 3.10% | 58,559 | - |
| 384 | EXOZ | eXoZymes, Inc. | 89.03M | 0.19% | 1,095 | -700.00 |
| 385 | GANX | Gain Therapeutics, Inc. | 86.17M | -2.39% | 337,880 | - |
| 386 | LONA | LeonaBio, Inc. | 86.04M | -0.65% | 25,490 | - |
| 387 | ATHE | Alterity Therapeutics Limited | 85.67M | -6.49% | 23,751 | 4.43M |
| 388 | OKYO | OKYO Pharma Limited | 85.02M | 4.52% | 22,983 | - |
| 389 | NRXS | NeurAxis, Inc. | 84.02M | 3.16% | 365,137 | 3.57M |
| 390 | CSBR | Champions Oncology, Inc. | 83.46M | 3.62% | 8,603 | 57.95M |
| 391 | ATYR | aTyr Pharma, Inc. | 82.78M | 2.53% | 751,307 | 190.00K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 82.51M | 3.03% | 288,848 | - |
| 393 | FLNA | Filana Therapeutics, Inc. | 81.64M | -0.59% | 260,005 | - |
| 394 | MCRB | Seres Therapeutics, Inc. | 80.91M | -0.71% | 51,537 | 789.00K |
| 395 | PLRX | Pliant Therapeutics, Inc. | 79.87M | - | 1,164,989 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 78.93M | 1.37% | 286,567 | - |
| 397 | IMMP | Immutep Limited | 78.10M | 0.41% | 4,315,215 | 5.28M |
| 398 | PTHS | Pelthos Therapeutics Inc. | 77.18M | - | 19,351 | 16.80M |
| 399 | XBIT | XBiotech Inc. | 77.13M | 0.40% | 11,072 | - |
| 400 | ESLA | Estrella Immunopharma, Inc. | 76.80M | -0.55% | 6,879 | - |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 76.33M | 11.93% | 6,138,881 | - |
| 402 | TCRX | TScan Therapeutics, Inc. | 75.13M | -1.57% | 741,394 | 10.33M |
| 403 | FBIO | Fortress Biotech, Inc. | 72.46M | 0.90% | 238,600 | 63.26M |
| 404 | PDSB | PDS Biotechnology Corporation | 72.00M | -3.73% | 542,167 | - |
| 405 | IBO | Impact BioMedical Inc. | 71.21M | -5.33% | 30,560 | 32.00K |
| 406 | ICCC | ImmuCell Corporation | 70.57M | 1.04% | 5,234 | 27.64M |
| 407 | MNOV | MediciNova, Inc. | 69.40M | -0.70% | 7,462 | 409.66K |
| 408 | OKUR | OnKure Therapeutics, Inc. | 68.50M | 2.66% | 136,267 | - |
| 409 | IMA | ImageneBio, Inc. | 67.22M | 3.44% | 51,960 | 800.00K |
| 410 | BYSI | BeyondSpring Inc. | 67.03M | -6.32% | 24,510 | 1.88M |
| 411 | GRCE | Grace Therapeutics, Inc. | 66.69M | -7.51% | 1,255,169 | - |
| 412 | IBIO | iBio, Inc. | 66.32M | - | 758,850 | 300.00K |
| 413 | ACTU | Actuate Therapeutics, Inc. | 65.92M | 22.74% | 202,593 | - |
| 414 | CING | Cingulate Inc. | 65.24M | -4.27% | 611,700 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 64.57M | 4.84% | 97,710 | 20.70M |
| 416 | ANVS | Annovis Bio, Inc. | 63.54M | -1.08% | 811,027 | - |
| 417 | EDSA | Edesa Biotech, Inc. | 62.47M | -8.10% | 211,019 | - |
| 418 | OSTX | OS Therapies Incorporated | 60.11M | 3.62% | 532,385 | - |
| 419 | TIL | Instil Bio, Inc. | 57.04M | 1.08% | 11,385 | - |
| 420 | ENTX | Entera Bio Ltd. | 56.88M | 2.52% | 102,493 | 42.00K |
| 421 | CUE | Cue Biopharma, Inc. | 56.65M | -13.42% | 10,306,854 | 27.47M |
| 422 | INKT | MiNK Therapeutics, Inc. | 56.31M | -3.41% | 33,448 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 55.68M | -1.33% | 139,230 | 25.21M |
| 424 | KZR | Kezar Life Sciences, Inc. | 53.89M | 0.21% | 27,658 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 53.30M | -0.32% | 29,903 | 10.86M |
| 426 | RNTX | Rein Therapeutics Inc. | 52.71M | 0.53% | 184,057 | - |
| 427 | PSTV | Plus Therapeutics, Inc. | 52.29M | 6.72% | 431,577 | 5.21M |
| 428 | MREO | Mereo BioPharma Group plc | 51.30M | -0.80% | 1,654,473 | 500.00K |
| 429 | ATOS | Atossa Therapeutics, Inc. | 51.24M | 3.12% | 40,176 | - |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 51.10M | 0.33% | 101,340 | - |
| 431 | NTRB | Nutriband Inc. | 50.69M | -0.24% | 3,091 | 2.28M |
| 432 | XLO | Xilio Therapeutics, Inc. | 49.73M | 0.94% | 22,150 | 43.77M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 47.10M | -1.44% | 75,115 | - |
| 434 | HYPD | Hyperion DeFi, Inc. | 45.34M | 1.79% | 267,226 | 813.46K |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 45.32M | 3.07% | 92,815 | 1.14M |
| 436 | RLYB | Rallybio Corporation | 45.23M | 3.14% | 22,467 | 858.00K |
| 437 | LIXT | Lixte Biotechnology Holdings, Inc. | 44.50M | 10.06% | 39,441 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 43.65M | -7.89% | 1,380,959 | 90.00K |
| 439 | LITS | Lite Strategy, Inc. | 43.27M | 5.31% | 121,530 | - |
| 440 | NXTC | NextCure, Inc. | 42.72M | 9.39% | 158,096 | - |
| 441 | RNXT | RenovoRx, Inc. | 42.72M | -0.09% | 144,379 | 1.12M |
| 442 | SNSE | Sensei Biotherapeutics, Inc. | 42.41M | 4.22% | 11,746 | - |
| 443 | ATRA | Atara Biotherapeutics, Inc. | 42.36M | 3.81% | 61,506 | 120.77M |
| 444 | PTN | Palatin Technologies, Inc. | 40.41M | 2.17% | 3,467 | 8.96M |
| 445 | ALGS | Aligos Therapeutics, Inc. | 40.28M | -0.76% | 186,055 | 2.19M |
| 446 | VERU | Veru Inc. | 39.16M | 2.95% | 56,026 | 16.89M |
| 447 | INMB | INmune Bio Inc. | 38.02M | 4.38% | 136,930 | 50.00K |
| 448 | CRVO | CervoMed Inc. | 36.48M | 1.29% | 57,182 | 4.01M |
| 449 | EVAX | Evaxion A/S | 35.61M | -5.11% | 31,359 | 7.53M |
| 450 | SNTI | Senti Biosciences, Inc. | 35.50M | 3.64% | 101,828 | 22.00K |
| 451 | BOLD | Boundless Bio, Inc. | 34.96M | -1.27% | 200,657 | - |
| 452 | TVGN | Tevogen Bio Holdings Inc. | 33.90M | -5.90% | 13,242 | - |
| 453 | CELU | Celularity Inc. | 33.74M | -4.10% | 54,533 | 40.58M |
| 454 | PLUR | Pluri Inc. | 33.67M | 0.12% | 4,295 | 1.34M |
| 455 | IGC | IGC Pharma, Inc. | 33.63M | 10.17% | 4,035,472 | 1.11M |
| 456 | DARE | Daré Bioscience, Inc. | 33.05M | -3.81% | 463,537 | 1.03M |
| 457 | SKYE | Skye Bioscience, Inc. | 31.61M | 9.08% | 234,680 | - |
| 458 | LSTA | Lisata Therapeutics, Inc. | 30.89M | 7.55% | 77,794 | 170.00K |
| 459 | OTLK | Outlook Therapeutics, Inc. | 30.36M | -9.14% | 9,213,788 | 205.70K |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 30.30M | 2.22% | 25,728 | - |
| 461 | DYAI | Dyadic International, Inc. | 30.24M | -0.78% | 102,098 | 3.09M |
| 462 | LGVN | Longeveron Inc. | 30.16M | 0.98% | 399,500 | 1.20M |
| 463 | LTRN | Lantern Pharma Inc. | 30.04M | - | 216,657 | - |
| 464 | ABVC | ABVC BioPharma, Inc. | 29.16M | -7.09% | 108,475 | 797.92K |
| 465 | KYNB | Kyntra Bio, Inc. | 29.10M | 1.84% | 17,469 | 6.44M |
| 466 | APLM | Apollomics, Inc. | 28.96M | 2.82% | 3,527 | 6.93M |
| 467 | NNVC | NanoViricides, Inc. | 28.94M | 6.35% | 233,574 | - |
| 468 | BCTX | BriaCell Therapeutics Corp. | 28.61M | -2.01% | 183,728 | - |
| 469 | AEON | AEON Biopharma, Inc. | 27.58M | 0.93% | 52,497 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 27.41M | 1.99% | 328,079 | - |
| 471 | CVM | CEL-SCI Corporation | 27.03M | -12.34% | 216,633 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 26.58M | 1.23% | 33,693 | 14.99M |
| 473 | TPST | Tempest Therapeutics, Inc. | 26.54M | 4.52% | 164,898 | - |
| 474 | PLRZ | Polyrizon Ltd. | 26.10M | 17.40% | 82,703 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 25.68M | -1.28% | 50,970 | 3.55M |
| 476 | BRNS | Barinthus Biotherapeutics plc | 25.54M | 6.95% | 31,459 | 14.97M |
| 477 | NRSN | NeuroSense Therapeutics Ltd. | 24.83M | 1.78% | 94,496 | - |
| 478 | CRIS | Curis, Inc. | 24.56M | 2.52% | 283,151 | 9.44M |
| 479 | LEXX | Lexaria Bioscience Corp. | 24.04M | 2.19% | 116,380 | 368.00K |
| 480 | SER | Serina Therapeutics, Inc. | 24.01M | -4.41% | 65,705 | 130.00K |
| 481 | VTGN | Vistagen Therapeutics, Inc. | 23.87M | -0.50% | 7,713,717 | 789.00K |
| 482 | XCUR | Exicure, Inc. | 23.19M | -3.24% | 36,370 | 500.00K |
| 483 | QNCX | Quince Therapeutics, Inc. | 22.33M | 2.24% | 1,517,749 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 22.15M | 1.45% | 130,796 | 320.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.57M | 1.16% | 45,231 | 570.00K |
| 486 | PBM | Psyence Biomedical Ltd. | 20.57M | -5.48% | 2,174,860 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 20.27M | 2.80% | 88,449 | - |
| 488 | PASG | Passage Bio, Inc. | 19.66M | -0.81% | 156,556 | - |
| 489 | QNTM | Quantum BioPharma Ltd. | 19.42M | -2.62% | 442,186 | - |
| 490 | OSRH | OSR Holdings, Inc. | 19.40M | -0.70% | 397,218 | 2.91M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 19.24M | 1.78% | 166,613 | 3.94M |
| 492 | ICU | SeaStar Medical Holding Corporation | 17.81M | 3.96% | 73,956 | 1.23M |
| 493 | KTTA | Pasithea Therapeutics Corp. | 17.71M | 2.90% | 230,256 | - |
| 494 | LPCN | Lipocine Inc. | 17.67M | 2.98% | 248,155 | 1.98M |
| 495 | TOVX | Theriva Biologics, Inc. | 17.12M | 10.16% | 22,371,215 | - |
| 496 | GNTA | Genenta Science S.p.A. | 16.84M | 3.48% | 23,312 | - |
| 497 | NCEL | NewcelX Ltd. | 16.68M | 8.28% | 196,873 | - |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 16.28M | -3.57% | 107,995 | 21.80K |
| 499 | HIND | Vyome Holdings, Inc. | 15.93M | 0.44% | 25,728 | 319.71K |
| 500 | HOTH | Hoth Therapeutics, Inc. | 15.27M | 6.43% | 714,188 | - |